These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3771670

  • 21. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I.
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [Abstract] [Full Text] [Related]

  • 22. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S, Tomita H, Yoshida M, Hori T, Igarashi C, Fujita S.
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [Abstract] [Full Text] [Related]

  • 23. [Blood coagulation changes in lung surgery and their prevention by heparin].
    Ruseĭkin NS, Gur'ianov VN.
    Grudn Khir; 1989 Sep; (4):47-50. PubMed ID: 2792878
    [Abstract] [Full Text] [Related]

  • 24. [LeVeen's peritoneojugular shunt for the treatment of ascites].
    Ouwendijk RJ, Schalm SW, Bauer AG, de Groot GH, Terpstra OT, van Urk H.
    Ned Tijdschr Geneeskd; 1982 May 22; 126(21):940-4. PubMed ID: 7099287
    [No Abstract] [Full Text] [Related]

  • 25. [Pro and con: Consumption coagulopathy--heparin treatment? Arguments in favor of heparin treatment].
    Lasch HG, Müller-Berghaus G.
    Internist (Berl); 1980 Jul 22; 21(7):382-4. PubMed ID: 7007274
    [No Abstract] [Full Text] [Related]

  • 26. [Recommendations for initial diagnosis and therapy in acute blood coagulation disorders].
    Sütterlin R, Barthels D.
    Anaesthesiol Reanim; 1996 Jul 22; 21(3):76-80. PubMed ID: 8766399
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy].
    Audibert G, Lambert H, Toulemonde F, Alexandre P, Laprevote-Heully MC, Bollaert PE, Bauer P, Larcan A.
    J Mal Vasc; 1987 Jul 22; 12 Suppl B():147-51. PubMed ID: 2834489
    [Abstract] [Full Text] [Related]

  • 30. The treatment of consumption coagulopathy.
    Vogel GE.
    Behring Inst Mitt; 1986 Feb 22; (79):191-9. PubMed ID: 3718406
    [Abstract] [Full Text] [Related]

  • 31. [Early changes of the coagulation system in multiple injuries and their modification with heparin and Trasylol].
    Kolbow H, Barthels M, Oestern HJ, Sturm J, Wannske M, Schaps D.
    Chir Forum Exp Klin Forsch; 1977 Apr 22; ():119-23. PubMed ID: 376236
    [Abstract] [Full Text] [Related]

  • 32. Effect of continuous low-dose intravenous heparin administered during operation on postoperative measurements of antithrombin III and antifactor Xa.
    Jennings SA, Heather BP, Greenhalgh RM.
    Surgery; 1984 Sep 22; 96(3):550-5. PubMed ID: 6474360
    [Abstract] [Full Text] [Related]

  • 33. [Antithrombin III in the acute promyelocytic leukemias].
    Roncalés FJ, Juncá J, Tuset E.
    Sangre (Barc); 1994 Apr 22; 39(2):148-9. PubMed ID: 8059294
    [No Abstract] [Full Text] [Related]

  • 34. [Heparin, low molecular weight heparin, heparinoid, and antithrombin III therapy of disseminated intravascular coagulation].
    Nakagawa M.
    Nihon Rinsho; 1993 Jan 22; 51(1):87-92. PubMed ID: 7679453
    [Abstract] [Full Text] [Related]

  • 35. [Value of physiological coagulation parameters in perioperative consumption coagulopathy using low heparin doses].
    Willmen HR, Angelkort B, Müther H, Wallat U, Wenzel E.
    Langenbecks Arch Chir; 1975 Jan 22; Suppl():423-6. PubMed ID: 1207272
    [Abstract] [Full Text] [Related]

  • 36. Current management of disseminated intravascular coagulation.
    Wheeler A, Rubenstein EB.
    Oncology (Williston Park); 1994 Sep 22; 8(9):69-73; discussion 73-6, 79. PubMed ID: 7993725
    [Abstract] [Full Text] [Related]

  • 37. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
    Sonzogni V, Bellavita P, Carrara B, Cossolini M, Ferri F, Fabretti F, Mamprin F, Pelliccioli I.
    Minerva Anestesiol; 2000 Sep 22; 66(1-2):17-23. PubMed ID: 10736978
    [Abstract] [Full Text] [Related]

  • 38. Antithrombin deficiency in special clinical syndromes--Part II: trauma/burns.
    Penner J.
    Semin Hematol; 1995 Oct 22; 32(4 Suppl 2):42-7; discussion 48. PubMed ID: 8821209
    [No Abstract] [Full Text] [Related]

  • 39. [The use of antithrombin III concentrates in disseminated intravascular coagulation].
    Aoki N, Matsuki K, Sakata Y.
    Rinsho Ketsueki; 1982 Jun 22; 23(6):804-10. PubMed ID: 7176087
    [No Abstract] [Full Text] [Related]

  • 40. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.
    Comerota AJ, Stewart GJ, White JV.
    Am J Surg; 1985 Oct 08; 150(4A):39-44. PubMed ID: 3901791
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.